XUE Yao-hui,YANG Zhou,XIAO Hang,et al.Efficacy of transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(11):948-951.
XUE Yao-hui,YANG Zhou,XIAO Hang,et al.Efficacy of transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(11):948-951. DOI: 10.11659/jjssx.01E023075.
Efficacy of transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis
To explore the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of acute and chronic portal vein thrombosis (PVT).
Methods
2
The clinical data of 12 PVT patients undergoing TIPS in our hospital were retrospectively analyzed. The success rate of surgery, the degree of thrombosis burden reduction, the change of portal vein pressure, the patency of portal vein, the relief of abdominal pain and bloating, and perioperative complications were observed.
Results
2
Twelve patients had successful TIPS surgery, with a success rate of surgery of 100%. There was no complications such as gastrointestinal and abdominal hemorrhage or hepatic encephalopathy during the perioperative period. One patient with acute PVT underwent significant thrombus resolution after catheter thrombolysis without subsequent stenting therapy; while the remaining 11 patients with chronic PVT all underwent stent implantation and gastric coronary vein embolization. In the postoperative re-examination, ultrasound or CT angiography examination of portal vein system showed the portal vein trunk and TIPS shunt stent had smooth blood flow.
Conclusion
2
TIPS is safe and feasible for the treatment of acute and chronic PVT, which can reduce the thrombotic burden and avoid liver and intestinal necrosis in patients with acute PVT. For chronic PVT, TIPS can effectively reshape the portal vein approach, decrease the portal vein pressure, and reduce gastrointestinal hemorrhage, abdominal fluid and other complications caused by portal hypertension.
Ögren M,Bergqvist D,Björck M,et al.Portal vein thrombosis:prevalence,patient characteristics and lifetime risk:a population study based on 23796 consecutive autopsies[J].World J Gastroenterol,2006,12(13):2115-2119.doi:10.3748/wjg.v12.i13.2115http://dx.doi.org/10.3748/wjg.v12.i13.2115.
Faccia M,Ainora ME,Ponziani FR,et al.Portal vein thrombosis in cirrhosis:why a well-known complication is still matter of debate[J].World J Gastroenterol,2019,25(31):4437-4451.doi:10.3748/wjg.v25.i31.4437http://dx.doi.org/10.3748/wjg.v25.i31.4437.
Alzubaidi S,Patel I,Saini A,et al.Current concepts in portal vein thrombosis:etiology,clinical presentation and management[J].Abdom Radiol (NY),2019,44(10):3453-3462.doi:10.1007/s00261-019-02174-1http://dx.doi.org/10.1007/s00261-019-02174-1.
Zocco MA,DiStasio E,DeCristofaro R,et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4):682-689.doi:10.1016/j.jhep.2009.03.013http://dx.doi.org/10.1016/j.jhep.2009.03.013.
European Association for the Study of the Liver.EASL clinical practice guidelines:vascular diseases of the liver[J].J Hepatol,2016,64(1):179-202.doi:10.1016/j.jhep.2015.07.040http://dx.doi.org/10.1016/j.jhep.2015.07.040.
Northup PG,Garcia-Pagan JC,Garcia-Tsao G,et al.Vascular liver disorders,portal vein thrombosis,and procedural bleeding in patients with liver disease:2020 practice guidance by the American Association for the Study of Liver Diseases[J].Hepatology,2021,73(1):366-413.doi:10.1002/hep.31646http://dx.doi.org/10.1002/hep.31646.
Wang Z,Jiang MS,Zhang HL,et al.Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis?A randomized controlled trial[J].Radiology,2016,279(3):943-951.doi:10.1148/radiol.2015150369http://dx.doi.org/10.1148/radiol.2015150369.
Rodrigues SG,Sixt S,Abraldes JG,et al.Systematic review with meta-analysis:portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis[J].Aliment Pharmacol Ther,2019,49(1):20-30.doi:10.1111/apt.15044http://dx.doi.org/10.1111/apt.15044.
Wolter K,Decker G,Kuetting D,et al.Interventional treatment of acute portal vein thrombosis[J].Rofo,2018,190(8):740-746.doi:10.1055/a-0631-9265http://dx.doi.org/10.1055/a-0631-9265.
Li Z,Zhang W,Jiao DC,et al.Clinical study of transjugular intrahepatic portosystemic shunt combined with AngioJet thrombectomy for acute portal vein thrombosis in non-cirrhosis[J].Medicine (Baltimore),2021,100(6):e24465.doi:10.1097/MD.0000000000024465http://dx.doi.org/10.1097/MD.0000000000024465.
Benmassaoud A,AlRubaiy L,Yu D,et al.A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia[J].Aliment Pharmacol Ther,2019,50:1049-1058.doi:10.1111/apt.15479http://dx.doi.org/10.1111/apt.15479.
Rosenqvist K,Barbier CE,Rorsman F,et al.Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt:a single-center experience[J].Acta Radiol,2018,59(8):953-958.doi:10.1177/0284185117742683http://dx.doi.org/10.1177/0284185117742683.
Uflacker R.Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis[J].Tech Vasc Interv Radiol,2003,6(1):59-69.doi:10.1053/tvir.2003.36433http://dx.doi.org/10.1053/tvir.2003.36433.
Zhang JB,Chen J,Zhou J,et al.Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis[J].World J Clin Cases,2021,9(19):5179-5190.doi:10.12998/wjcc.v9.i19.5179http://dx.doi.org/10.12998/wjcc.v9.i19.5179.